Skip to content
AnalystLens

Leidos Holdings 8-K Report, Financial Results (Feb 13, 2024)

Reports
Earnings & Results·Regulation FD·Exhibits & Filings
Filing Date
Filed February 13, 2024
Period End
February 13, 2024
Security
LDOS
In the record · 2016–202610-K1210-Q338-K130

LDOS filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Mar ’20Mar ’20
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Material agreement8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed February 13, 2024. Cited figures are marked; the original filing is the authoritative source.

Leidos Holdings, Inc. (NYSE: LDOS) reported fourth-quarter and fiscal 2023 results on February 13, 2024, with revenues of $3.98 billiona for the quarter (up 8% year-over-year) and $15.44 billion for the year (up 7%).

Diluted EPS was $1.66b for the quarter (up 30%) and $1.44 for the year (down 71%). The company said the annual decline was primarily due to pre-tax impairment and restructuring charges of $699 million, mainly associated with the Security Enterprise Solutions (SES) reporting unit recorded in the third quarter. Non-GAAP diluted EPS was $1.99 for the quarter (up 9%) and $7.30 for the year (up 11%), and adjusted EBITDA was $1.67 billion (10.8% margin) for the year.

Cash performance was solid: net cash provided by operating activities was $304 millionc in the quarter and $1.17 billion for the year, with free cash flow of $958 million for the year. The company returned $253 million to shareholders in the quarter, including $202 million in share repurchases, and declared a $0.38 per share dividend payable March 28, 2024. Net bookings were $16.5 billion for fiscal 2023, with a year-end backlog of $37.0 billion, of which $8.8 billion was funded.

Leidos initiated fiscal 2024 guidance calling for revenues of $15.7 to $16.1 billiond, an adjusted EBITDA margin in the mid-to-high 10% range, non-GAAP diluted EPS of $7.50 to $7.90, and operating cash flow of approximately $1.1 billion. The filing also reports that, effective December 30, 2023, the company adopted a new four-segment structure, with recast historical information provided in Exhibit 99.2.

Key Highlights

  1. Q4 2023 revenues of $3.98 billion rose 8% year-over-year, and full-year revenues of $15.44 billion rose 7%, driven by increased demand across all customer segments, especially Health.
  2. Full-year 2023 GAAP net income fell to $208 million ($1.44 diluted EPS) from $693 million, mainly due to $699 million of pre-tax impairment and restructuring charges tied largely to the SES reporting unit.
  3. Non-GAAP diluted EPS was $1.99 in Q4 (up 9%) and $7.30 for the full year (up 11%), and adjusted EBITDA reached $1.67 billion for the year at a 10.8% margin.
  4. Free cash flow was $226 million in Q4 and $958 million for the full year, with DSO improving to 56 days in the quarter.
  5. Net bookings were $16.5 billion for 2023 (book-to-bill of 1.1), and year-end backlog reached $37.0 billion, of which $8.8 billion was funded.
  6. FY24 guidance calls for revenues of $15.7 to $16.1 billion, adjusted EBITDA margin in the mid-to-high 10% range, non-GAAP diluted EPS of $7.50 to $7.90, and operating cash flow of approximately $1.1 billion, including about $60 million of cash tax payments related to R&D capitalization.
  7. Effective December 30, 2023, Leidos moved to four reportable segments (National Security and Digital, Health & Civil, Commercial & International, and Defense Systems), with recast unaudited historical financials provided in Exhibit 99.2.

Frequently Asked Questions

  1. Why did GAAP earnings decline so sharply in fiscal 2023 despite revenue growth?

    The filing attributes the decline to pre-tax impairment and restructuring charges of $699 million, mainly associated with the Security Enterprise Solutions (SES) reporting unit recorded in Q3 2023. Full-year GAAP net income was $208 million, or $1.44 per diluted share, down 70% and 71% respectively from fiscal 2022. Excluding these items, non-GAAP diluted EPS rose 11% to $7.30.

  2. What is the company's outlook for fiscal 2024?

    Leidos initiated FY24 guidance for revenues of $15.7 to $16.1 billion, an adjusted EBITDA margin in the mid-to-high 10% range, non-GAAP diluted EPS of $7.50 to $7.90, and cash flows from operating activities of approximately $1.1 billion. The company noted this cash flow guidance reflects approximately $60 million of cash tax payments related to the Tax Cuts and Jobs Act R&D capitalization provision, and that the company does not provide a GAAP reconciliation of these forward-looking non-GAAP measures.

  3. How strong is the company's order book and backlog?

    Net bookings were $2.8 billion in Q4 2023 (book-to-bill of 0.7) and $16.5 billion for fiscal 2023 (book-to-bill of 1.1). Backlog at fiscal year-end 2023 was $37.0 billion, compared with $35.8 billion at the end of fiscal 2022 as shown in the filing's backlog table, of which $8.8 billion was funded.

  4. What did the company do with its cash in the quarter and year?

    In Q4, Leidos generated $304 million from operations, used $76 million in investing activities, and used $245 million in financing activities. Financing included $202 million in share repurchases and $51 million in regular quarterly dividends. For the full year, operating cash flow was $1.17 billion and free cash flow was $958 million. The company had $777 million in cash and cash equivalents and $4.7 billion in debt at December 29, 2023. The Board declared a $0.38 per share dividend payable March 28, 2024.

  5. How did the individual segments perform?

    Under the prior segment structure, Defense Solutions revenues were $8.73 billion for the year (up 6%) with a 7.3% operating margin. Civil revenues were $3.66 billion (up 6%) with an operating margin of (11.3)% due to the SES impairment charges. Health revenues were $3.04 billion (up 13%) with a 17.4% operating margin. Health was the strongest performer, driven by higher medical examination volumes and incentive awards.